New Drug Treatment for Advanced Head and Neck Cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests a new cancer medication for people with head and neck cancer that has come back or spread to other parts of the body. The study aims to see if this drug can help slow or shrink the cancer and improve survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–75 years old
- Diagnosis of recurrent or metastatic head and neck cancer confirmed by biopsy or cell sample
- Good overall health status (able to care for yourself with minimal help)
- Expected to live longer than 3 months
- Blood work showing adequate liver, kidney, and bone marrow function
- Heart function test (echocardiogram) showing ejection fraction of at least 50%
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental oral capsule called TQB3019 for people with advanced blood cancers that have come back or not improved with other treatments. The goal is to see if the drug is safe and to find the right dose.
This trial tests a new drug, TQB6411, for people with advanced cancers that have not responded to standard treatments. It aims to see if the drug is safe and effective for different tumor types.
This trial tests a combination of chemotherapy directly into an artery, radiation, and immunotherapy for advanced head and neck cancer. It may offer a new treatment option for people whose cancer hasn't spread to other parts of the body.
This trial tests a new drug, TQB2922, for people with advanced cancers that have not responded to standard treatments. The goal is to see if it is safe and how it affects the cancer.
This trial tests a new drug called TQB2101 for people with advanced blood cancers that haven't improved with standard treatments. The goal is to see if the drug is safe and effective.
This trial is testing an experimental drug called CD-001 for people with advanced head and neck cancer who have run out of standard treatment options. The goal is to see if the drug is safe and if it can shrink tumors.
Hear when a new Recurrent/Metastatic Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.